NYSDA Publications

FDA Issues Guidance on AI Improving Health Care

Jun 17, 2024

Per the notice below, the United States Food and Drug Administration (FDA) has issued guidance on how artificial intelligence (AI) can be used to improve health care.

U.S. Food and Drug Administration, Center for Devices and Radiological Health

New Blog: The Promise of Artificial Intelligence for Improving Health Care

AI LifecycleArtificial intelligence (AI) is rapidly changing the health care industry and holds transformative potential, writes Troy Tazbaz, Director, Digital Health Center of Excellence (DHCoE), Center for Devices and Radiological Health, U.S. Food and Drug Administration, in a new blog post.

Among the possibilities AI offers are:

  • significantly improve patient care and medical professional satisfaction
  • accelerate and advance research in medical device development and drug discovery
  • drive operational efficiency by enabling personalized treatment and streamlining health care processes.

At the FDA, we know that the proper integration of AI across the health care ecosystem will be paramount to achieving its potential while reducing risks and challenges.

Questions?

Our “virtual” doors at the FDA’s Digital Health Center of Excellence are always open.  We welcome your comments and feedback related to AI use in health care.  E-mail us at digitalhealth@fda.hhs.gov, noting “Attn: AI in health care” in the subject line.